ArticleEcancermedicalscience2022

Retrospective analysis: checkpoint inhibitor accessibility for thoracic and head and neck cancers and factors influencing it in a tertiary centre in India.

Vijay Patil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.